Skip to main content
Cosmo Pharmaceuticals N.V. (SWX:COPN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
47.00
+0.50 (1.08%)
Apr 24, 2025, 3:43 PM CET

Cosmo Pharmaceuticals Revenue

In the year 2024, Cosmo Pharmaceuticals had annual revenue of 266.79M EUR with 187.55% growth. Cosmo Pharmaceuticals had revenue of 130.55M in the half year ending December 31, 2024, with 115.51% growth.

Revenue
266.79M EUR
Revenue Growth
+187.55%
P/S Ratio
2.98
Revenue / Employee
829.05K EUR
Employees
322
Market Cap
744.70M CHF

Revenue Chart

* This company reports financials in EUR.

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024266.79M174.01M187.55%
Dec 31, 202392.78M-9.31M-9.12%
Dec 31, 2022102.09M37.02M56.88%
Dec 31, 202165.07M4.13M6.77%
Dec 31, 202060.95M-1.55M-2.47%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 62.40B
Novartis AG 46.87B
Lonza Group AG 6.57B
Alcon 8.98B
Galderma Group AG 4.02B
Straumann Holding AG 2.50B
Sonova Holding AG 3.71B
Sandoz Group AG 9.41B
Revenue Rankings

Cosmo Pharmaceuticals News

More News